Skip to content

Effectiveness of Acceptance and Commitment-Based Therapy (ACT) on Positive and Negative Psychotic Symptoms and Emotion regulation in Patients with schizophrenia spectrum disorders

Evaluation of the effectiveness of Acceptance and Commitment-Based Therapy (ACT) on Positive and Negative Psychotic Symptoms and Emotion regulation of Patients with schizophrenia spectrum disorders: A Single-Subject study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210412050937N1
Enrollment
5
Registered
2021-07-22
Start date
2020-12-21
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia spectrum disorders. Schizophrenia

Interventions

Five patients with schizophrenia spectrum disorders participated in treatment sessions on a single-subject basis. The Acceptance and Commitment Therapy Manual consists of 16 sessions, each lasting 50
notice their own thoughts
contact the present moment
focus on their values
and act in accordance with their values. In each session, a complete asse

Sponsors

University of social welfare and rehabilitation sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Patients with the diagnosis of a psychiatrist based on DSM5 criteria, have positive and negative psychotic symptoms and their acute symptoms are in relative control Being at the age of 18 and 45 years Patients enter the study voluntarily and with informed consent or the opinion of the guardian Patient's score in the positive and negative symptoms questionnaire and in the emotional regulation questionnaire should be higher than other patients

Exclusion criteria

Exclusion criteria: Patients who have criminal and judicial problems in terms of the judiciary (due to possible problems in accessing to patients) Patients who have mental disorders other than schizophrenia according to a psychiatrist Patients who have a drug addiction problem for any reason or have been admitted to a psychiatric hospital due to substance abuse Patients with neurological disorders such as epilepsy, stroke, or severe concussion (based on patient records)

Design outcomes

Primary

MeasureTime frame
Positive and negative symptom score in Schizophrenia positive and negative symptom questionnaire. Timepoint: Measures of The Positive and Negative Symptoms two weeks before the start of the intervention (three baseline), all intervention sessions (16 Sessions), and 3 months after the end of the intervention (three follow-up lines). Method of measurement: The Positive and Negative Symptoms Questionnaire.;Emotional regulation score in the Gratz and Roemer Emotional Regulation Difficulties Questionnaire. Timepoint: Measures of emotional regulation two weeks before the start of the intervention (three baseline), all intervention sessions (16 sessions), and 3 months after the end of the intervention (three follow-up lines). Method of measurement: Gratz and Roemer Emotional Regulation Difficulties Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamid Khakbaz

University of social welfare and rehabilitation sciences

ham.khakbaz@uswr.ac.ir+98 21 5591 5322

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026